A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen von Kalimuddin, Shirin, Wijaya, Limin, Chan, Yvonne F.Z., Wong, Abigail W.L., Oh, Helen M.L., Wang, Lin-Fa, Kassim, Julaihabee A., Zhao, Jing, Shi, Zhongkai, Low, Jenny G.

Volltext

An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volun... von Wijaya, Limin, Tham, Christine Y.L, Chan, Yvonne F.Z, Wong, Abigail W.L, Li, L.T, Wang, Lin-Fa, Bertoletti, Antonio, Low, Jenny G

Volltext

Genomic signature of early T-cell response is associated with lower antibody titer threshold for sterilizing immunity von Ong, Eugenia Z., Gan, Esther S., de Alwis, Ruklanthi, Wijaya, Limin, Ong, Xin Mei, Zhang, Menglan, Wong, Abigail WL, Cheung, Yin Bun, Zellweger, Raphaël M., Ooi, Eng Eong, Low, Jenny G.

Volltext